Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Dow
Express Scripts
Moodys
Johnson and Johnson
Teva
Healthtrust
Julphar

Generated: July 21, 2018

DrugPatentWatch Database Preview

Ortho Mcneil Janssen Company Profile

« Back to Dashboard

What is the competitive landscape for ORTHO MCNEIL JANSSEN, and what generic alternatives to ORTHO MCNEIL JANSSEN drugs are available?

ORTHO MCNEIL JANSSEN has seven approved drugs.

There are two US patents protecting ORTHO MCNEIL JANSSEN drugs.

There are thirty-four patent family members on ORTHO MCNEIL JANSSEN drugs in seventeen countries and twelve supplementary protection certificates in eight countries.

Summary for Ortho Mcneil Janssen
International Patents:34
US Patents:2
Tradenames:9
Ingredients:6
NDAs:7

Drugs and US Patents for Ortho Mcneil Janssen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Janssen VIADUR leuprolide acetate IMPLANT;IMPLANTATION 021088-001 Mar 3, 2000 DISCN No No 6,375,978 ➤ Sign Up ➤ Sign Up
Ortho Mcneil Janssen ORTHO-NOVUM 10/11-21 ethinyl estradiol; norethindrone TABLET;ORAL-21 018354-001 Jan 11, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Ortho Mcneil Janssen TOLECTIN 600 tolmetin sodium TABLET;ORAL 017628-002 Mar 8, 1989 DISCN No No ➤ Sign Up ➤ Sign Up
Ortho Mcneil Janssen TOLECTIN DS tolmetin sodium CAPSULE;ORAL 018084-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Ortho Mcneil Janssen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil Janssen VIADUR leuprolide acetate IMPLANT;IMPLANTATION 021088-001 Mar 3, 2000 6,124,261 ➤ Sign Up
Ortho Mcneil Janssen VIADUR leuprolide acetate IMPLANT;IMPLANTATION 021088-001 Mar 3, 2000 6,132,420 ➤ Sign Up
Ortho Mcneil Janssen TOLECTIN DS tolmetin sodium CAPSULE;ORAL 018084-001 Approved Prior to Jan 1, 1982 3,752,826 ➤ Sign Up
Ortho Mcneil Janssen VIADUR leuprolide acetate IMPLANT;IMPLANTATION 021088-001 Mar 3, 2000 6,156,331 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Ortho Mcneil Janssen Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00221 Netherlands ➤ Sign Up PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
49/2008 Austria ➤ Sign Up PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON
2016 00016 Denmark ➤ Sign Up PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
2006 00038 Denmark ➤ Sign Up PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Deloitte
Argus Health
McKinsey
Harvard Business School
Daiichi Sankyo
Chinese Patent Office
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.